Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3265281000168116 | Imfinzi (durvalumab 500 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3265291000168118 | Imfinzi 500 mg/10 mL injection, 10 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Imfinzi 500 mg/10 mL injection, 10 mL vial | Is a | Imfinzi | true | Inferred relationship | Some | ||
| Imfinzi 500 mg/10 mL injection, 10 mL vial | Is a | durvalumab 500 mg/10 mL injection, vial | true | Inferred relationship | Some | ||
| Imfinzi 500 mg/10 mL injection, 10 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Imfinzi 500 mg/10 mL injection, 10 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Imfinzi 500 mg/10 mL injection, 10 mL vial | has unit of use | vial | true | Inferred relationship | Some | 2050340841 | |
| Imfinzi 500 mg/10 mL injection, 10 mL vial | has intended active ingredient | durvalumab | true | Inferred relationship | Some | 2050340840 | |
| Imfinzi 500 mg/10 mL injection, 10 mL vial | has Australian BoSS | durvalumab | true | Inferred relationship | Some | 2050340840 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Imfinzi 500 mg/10 mL injection, 10 mL vial | has TPUU | True | Imfinzi 500 mg/10 mL injection, 10 mL vial | Inferred relationship | Some | 1 |
| Imfinzi (durvalumab 500 mg / 10 mL) injection, 1 x 10 mL vial (trade product pack) | has TPUU | True | Imfinzi 500 mg/10 mL injection, 10 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR